vs

Side-by-side financial comparison of CAPRICOR THERAPEUTICS, INC. (CAPR) and Cherry Hill Mortgage Investment Corp (CHMI). Click either name above to swap in a different company.

Cherry Hill Mortgage Investment Corp is the larger business by last-quarter revenue ($11.8M vs $11.1M, roughly 1.1× CAPRICOR THERAPEUTICS, INC.). On growth, CAPRICOR THERAPEUTICS, INC. posted the faster year-over-year revenue change (-7.9% vs -37.2%). Over the past eight quarters, CAPRICOR THERAPEUTICS, INC.'s revenue compounded faster (93.0% CAGR vs -15.2%).

Capricor Therapeutics is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative biological therapies including cell and gene therapies for rare diseases, cardiovascular disorders and muscular conditions. It primarily operates in the U.S. market, addressing unmet medical needs for patient groups with limited treatment options.

Cherry Hill Mortgage Investment Corp is a U.S.-headquartered real estate finance firm focused on acquiring, investing in and managing residential mortgage-related assets. Its core holdings include agency mortgage-backed securities, residential loans and mortgage servicing rights, operating primarily in the U.S. domestic housing finance market.

CAPR vs CHMI — Head-to-Head

Bigger by revenue
CHMI
CHMI
1.1× larger
CHMI
$11.8M
$11.1M
CAPR
Growing faster (revenue YoY)
CAPR
CAPR
+29.3% gap
CAPR
-7.9%
-37.2%
CHMI
Faster 2-yr revenue CAGR
CAPR
CAPR
Annualised
CAPR
93.0%
-15.2%
CHMI

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CAPR
CAPR
CHMI
CHMI
Revenue
$11.1M
$11.8M
Net Profit
$-7.1M
Gross Margin
78.9%
Operating Margin
-69.1%
72.1%
Net Margin
-63.9%
Revenue YoY
-7.9%
-37.2%
Net Profit YoY
-833.8%
EPS (diluted)
$-0.11
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPR
CAPR
CHMI
CHMI
Q4 25
$11.8M
Q3 25
$8.6M
Q2 25
$6.0M
Q1 25
$-3.0M
Q4 24
$11.1M
$18.7M
Q3 24
$2.3M
$-7.1M
Q2 24
$4.0M
$6.6M
Q1 24
$4.9M
$16.3M
Net Profit
CAPR
CAPR
CHMI
CHMI
Q4 25
Q3 25
$4.5M
Q2 25
$1.6M
Q1 25
$-7.0M
Q4 24
$-7.1M
Q3 24
$-12.6M
$-12.4M
Q2 24
$-11.0M
$784.0K
Q1 24
$-9.8M
$12.1M
Gross Margin
CAPR
CAPR
CHMI
CHMI
Q4 25
78.9%
Q3 25
73.2%
Q2 25
67.7%
Q1 25
183.4%
Q4 24
83.3%
Q3 24
145.3%
Q2 24
47.5%
Q1 24
83.9%
Operating Margin
CAPR
CAPR
CHMI
CHMI
Q4 25
72.1%
Q3 25
56.0%
Q2 25
44.4%
Q1 25
223.6%
Q4 24
-69.1%
76.2%
Q3 24
-575.2%
171.8%
Q2 24
-291.9%
22.0%
Q1 24
-209.2%
78.0%
Net Margin
CAPR
CAPR
CHMI
CHMI
Q4 25
Q3 25
52.7%
Q2 25
25.9%
Q1 25
229.2%
Q4 24
-63.9%
Q3 24
-555.2%
175.8%
Q2 24
-277.0%
11.9%
Q1 24
-199.6%
73.7%
EPS (diluted)
CAPR
CAPR
CHMI
CHMI
Q4 25
$0.18
Q3 25
$0.05
Q2 25
$-0.03
Q1 25
$-0.29
Q4 24
$-0.11
$0.30
Q3 24
$-0.38
$-0.49
Q2 24
$-0.35
$-0.06
Q1 24
$-0.31
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPR
CAPR
CHMI
CHMI
Cash + ST InvestmentsLiquidity on hand
$151.5M
$54.9M
Total DebtLower is stronger
$146.3M
Stockholders' EquityBook value
$145.5M
$236.0M
Total Assets
$170.5M
$1.5B
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPR
CAPR
CHMI
CHMI
Q4 25
$54.9M
Q3 25
$55.4M
Q2 25
$58.0M
Q1 25
$47.3M
Q4 24
$151.5M
$46.3M
Q3 24
$85.0M
$50.2M
Q2 24
$29.5M
$52.4M
Q1 24
$39.9M
$47.5M
Total Debt
CAPR
CAPR
CHMI
CHMI
Q4 25
$146.3M
Q3 25
$148.0M
Q2 25
$150.1M
Q1 25
$150.1M
Q4 24
$152.1M
Q3 24
$151.8M
Q2 24
$160.5M
Q1 24
$167.5M
Stockholders' Equity
CAPR
CAPR
CHMI
CHMI
Q4 25
$236.0M
Q3 25
$233.1M
Q2 25
$229.9M
Q1 25
$226.6M
Q4 24
$145.5M
$230.3M
Q3 24
$68.3M
$236.7M
Q2 24
$11.5M
$234.5M
Q1 24
$18.4M
$247.0M
Total Assets
CAPR
CAPR
CHMI
CHMI
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.4B
Q4 24
$170.5M
$1.5B
Q3 24
$93.0M
$1.6B
Q2 24
$38.3M
$1.4B
Q1 24
$49.4M
$1.4B
Debt / Equity
CAPR
CAPR
CHMI
CHMI
Q4 25
0.62×
Q3 25
0.63×
Q2 25
0.65×
Q1 25
0.66×
Q4 24
0.66×
Q3 24
0.64×
Q2 24
0.68×
Q1 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPR
CAPR
CHMI
CHMI
Operating Cash FlowLast quarter
$-14.8M
$19.1M
Free Cash FlowOCF − Capex
$-15.3M
FCF MarginFCF / Revenue
-137.3%
Capex IntensityCapex / Revenue
4.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPR
CAPR
CHMI
CHMI
Q4 25
$19.1M
Q3 25
$-2.4M
Q2 25
$12.5M
Q1 25
$682.0K
Q4 24
$-14.8M
$-4.7M
Q3 24
$-11.6M
$4.4M
Q2 24
$-12.3M
$4.1M
Q1 24
$-1.3M
$-19.1M
Free Cash Flow
CAPR
CAPR
CHMI
CHMI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-15.3M
Q3 24
$-11.7M
Q2 24
$-12.3M
Q1 24
$-1.9M
FCF Margin
CAPR
CAPR
CHMI
CHMI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-137.3%
Q3 24
-515.2%
Q2 24
-310.9%
Q1 24
-38.3%
Capex Intensity
CAPR
CAPR
CHMI
CHMI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
4.4%
Q3 24
0.4%
Q2 24
1.5%
Q1 24
12.4%
Cash Conversion
CAPR
CAPR
CHMI
CHMI
Q4 25
Q3 25
-0.53×
Q2 25
7.98×
Q1 25
Q4 24
Q3 24
Q2 24
5.18×
Q1 24
-1.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons